title: Primary multiple cerebral invasion in acute promyelocytic leukemia dramatically worsened by all-trans retinoic acid.
authors.forename: Tsunayuki
authors.initials: T
authors.lastname: Kakimoto
authors.forename: Yosuke
authors.initials: Y
authors.lastname: Takahashi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Watanabe
authors.forename: Motoshi
authors.initials: M
authors.lastname: Matsuzawa
authors.forename: Yukinari
authors.initials: Y
authors.lastname: Sanada
authors.forename: Kazuhito
authors.initials: K
authors.lastname: Suzuki
authors.forename: Ai
authors.initials: A
authors.lastname: Mihara
authors.forename: Sachiko
authors.initials: S
authors.lastname: Yoshida
authors.forename: Tomonori
authors.initials: T
authors.lastname: Nakazato
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001409:Bacillus cereus; D001424:Bacterial Infections / Q000188:drug therapy; D001922:Brain Abscess / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D007278:Injections, Spinal; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000008:administration & dosage; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000970:Antineoplastic Agents; D003561:Cytarabine; D014212:Tretinoin; D008727:Methotrexate; D015255:Idarubicin